‘Question Id: 22785

= tem 23 of 40 5 v Mark <q Se rc j @ él

e
Previous Next Full Screen Tutorial Lab Values

Researchers are investigating the use of immune checkpoint inhibitors for the treatment of
advanced colorectal cancer. They find that this therapy is more effective in patients with DNA
mismatch-repair deficiency compared to patients with an intact mismatch-repair mechanism.
Which of the following most likely explains the improved efficacy of the drug in the first group

of patients?

JY _ A. Higher burden of tumor neoantigens (50%)
B. Increased MHC class | expression in tumor cells (19%)
C. Increased number of regulatory T cells (7%)
D. Increased synthesis of metalloproteinases (7%)

E. Lower frequency of DNA mutations (14%)

Omitted

hl 50% 05 secs c4 2022
_ BOECST a pe meren leo erty Time Spent Version
Explanation

Block Time Elapse

Tutor

g e GA)

Notes Calculator Reverse Color __Text Zoom

Activate Windows

63

Settings

End Blox
